The synovial sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation

Cancer Research

Volumn 66, Issue 19, 2006, Pages 9474-9482

  De Bruijn, Diederik R H ^a   Allander, Susanne V ^b   Van Dijk, Anke H A ^a   Willemse, Marieke P ^a   Thijssen, Jose ^a   Van Groningen, Jan J M ^a   Meltzer, Paul S ^b   Van Kessel, Ad Geurts ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; EPIDERMAL GROWTH FACTOR; HERMES ANTIGEN; HYBRID PROTEIN; NUCLEAR PROTEIN; REPRESSOR PROTEIN; SOMATOMEDIN; SS18 PROTEIN; SSX2 PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; DOWN REGULATION; EPIGENETICS; GENE CONTROL; GENE TARGETING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVIAL SARCOMA; TRANSCRIPTION INITIATION; UNINDEXED SEQUENCE; UPREGULATION;

CHOLESTEROL; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; INSULIN-LIKE GROWTH FACTOR II; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS, FUSION; PROTEIN STRUCTURE, TERTIARY; REPRESSOR PROTEINS; SARCOMA, SYNOVIAL; SOMATOMEDINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC;

EID: 33750312177     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-3726     Document Type: Article

References (55)

1. Ladanyi M, Antonescu CR, Leung DH, et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res 2002;62:135-40.
2. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Synovial sarcoma. Cancer Genet Cytogenet 2002;133:1-23.
3. Clark J, Rocques PJ, Crew AJ, et al. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 1994;7:502-8.
4. de Leeuw B, Balemans M, Olde Weghuis D, Geurts van Kessel A. Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X;18)(p11.2;q11.2)-positive synovial. Hum Mol Genet 1995;4:1097-9.
5. Crew AJ, Clark J, Fisher C, et al. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J 1995;14:2333-40.
6. Skytting B, Nilsson G, Brodin B, et al. A novel fusion gene, SYT-SSX4, in synovial sarcoma. J Natl Cancer Inst 1999;91:974-5.
7. de Bruijn DR, Baats E, Zechner U, et al. Isolation and characterization of the mouse homolog of SYT, a gene implicated in the development of human synovial sarcomas. Oncogene 1996;13:643-8.
8. de Bruijn DR, Kater-Baats E, Eleveld M, Merkx G, Geurts van Kessel A. Mapping and characterization of the mouse and human SS18 genes, two human SS18-like genes and a mouse Ss18 pseudogene. Cytogenet Cell Genet 2001;92:310-9.
9. dos Santos NR, de Bruijn DR, Balemans M, et al. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins. Hum Mol Genet 1997;6:1549-58.
10. Brett D, Whitehouse S, Antonson P, Shipley J, Cooper C, Goodwin G. The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies. Hum Mol Genet 1997;6:1559-64.
11. Thaete C, Brett D, Monaghan P, et al. Functional domains of the SYT and SYT-SSX synovial sarcoma translocation proteins and co-localization with the SNF protein BRM in the nucleus. Hum Mol Genet 1999;8:585-91.
12. de Bruijn DR, dos Santos NR, Thijssen J, et al. The synovial sarcoma associated protein SYT interacts with the acute leukemia associated protein AF10. Oncogene 2001;20:3281-9.
13. Debernardi S, Bassini A, Jones LK, et al. The MLL fusion partner AF10 binds GAS41, a protein that interacts with the human SWI/SNF complex. Blood 2002;99:275-81.
14. Kato H, Tjernberg A, Zhang W, et al. SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets. J Biol Chem 2002;277:5498-505.
15. Dingwall AK, Beek SJ, McCallum CM, et al. The Drosophila snr1 and brm proteins are related to yeast SWI/SNF proteins and are components of a large protein. Mol Biol Cell 1995;6:777-91.
16. Perani M, Ingram CJ, Cooper CS, Garrett MD, Goodwin GH. Conserved SNH domain of the proto-oncoprotein SYT interacts with components of the human chromatin remodelling complexes, whereas the QPGY repeat domain forms homo-oligomers. Oncogene 2003;22:8156-67.
17. Eid JE, Kung AL, Scully R, Livingston DM. p300 interacts with the nuclear proto-oncoprotein SYT as part of the active control of cell adhesion. Cell 2000;102:839-48.
18. Ito T, Ouchida M, Ito S, et al. SYT, a partner of SYT-SSX oncoprotein in synovial sarcomas, interacts with mSin3A, a component of histone deacetylase complex. Lab Invest 2004;84:1484-90.
19. Li S, Armstrong CM, Bertin N, et al. A map of the interactome network of the metazoan C. elegans. Science 2004;303:540-3.
20. Gure AO, Wei IJ, Old LJ, Chen YT. The SSX gene family: characterization of 9 complete genes. Int J Cancer 2002;101:448-53.
21. Margolin JF, Friedman JR, Meyer WK, Vissing H, Thiesen HJ, Rauscher FJ III. Kruppel-associated boxes are potent transcriptional repression domains. Proc Natl Acad Sci U S A 1994;91:4509-13.
22. Lim FL, Soulez M, Koczan D, Thiesen HJ, Knight JC. A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas. Oncogene 1998;17:2013-8.
23. dos Santos NR, de Bruijn DR, Kater-Baats E, Otte AP, Geurts van Kessel A. Delineation of the protein domains responsible for SYT, SSX SYT-SSX nuclear localization. Exp Cell Res 2000;256:192-202.
24. Soulez M, Saurin AJ, Freemont PS, Knight JC. SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co-localize with the human Polycomb group. Oncogene 1999;18:2739-46.
25. Satijn DP, Otte AP. Polycomb group protein complexes: do different complexes regulate distinct target genes? Biochim Biophys Acta 1999;1447:1-16.
26. Allander SV, Illei PB, Chen Y, et al. Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. Am J Pathol 2002;161:1587-95.
27. Boyd KE, Wells J, Gutman J, Hartley SM, Farnham PJ. c-Myc target gene specificity is determined by a post-DNA binding mechanism. Proc Natl Acad Sci U S A 1998;95:13887-92.
28. Frommer M, McDonald LE, Millar DS, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 1992;89:1827-31.
29. Li EC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002;18:1427-31.
30. Nagai M, Tanaka S, Tsuda M, et al. Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2α. Proc Natl Acad Sci U S A 2001;98:3843-8.
31. Zhang F, Lin M, Abidi P, Thiel G, Liu J. Specific interaction of Egr1 and c/EBPβ leads to the transcriptional activation of the human low density lipoprotein receptor gene. J Biol Chem 2003;278:44246-54.
32. Siu F, Chen C, Zhong C, Kilberg MS. CCAAT/enhancer-binding protein-β is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene. J Biol Chem 2001;276:48100-7.
33. Rao KN. The significance of the cholesterol biosynthetic pathway in cell growth and carcinogenesis [review]. Anticancer Res 1995;15:309-14.
34. Rainey WE, Carr BR, Wang ZN, Parker CR, Jr. Gene profiling of human fetal and adult adrenals. J Endocrinol 2001;171:209-15.
35. Lee YF, John M, Edwards S, et al. Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling. Br J Cancer 2003;88:510-5.
36. Holley SJ, Hall SB, Mellon PE. Complementary expression of IGF-II and IGFBP-5 during anterior pituitary development. Dev Biol 2002;244:319-28.
37. Allan GJ, Zannoni A, McKinnell I, et al. Major components of the insulin-like growth factor axis are expressed early in chicken embryogenesis, with IGF binding protein (IGFBP)-5 expression subject to regulation by Sonic Hedgehog. Anat Embryol (Berl) 2003;207:73-84.
38. Black EJ, Clair T, Delrow J, Neiman P, Gillespie DA. Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun. Oncogene 2004;23:2357-66.
39. Fu M, Zhu X, Zhang J, et al. Egr-1 target genes in human endothelial cells identified by microarray analysis. Gene 2003;315:33-41.
40. Ito T, Yamauchi M, Nishina M, et al. Identification of SWI SNF complex subunit BAF60a as a determinant of the transactivation potential of Fos/Jun. J Biol Chem 2001;276:2852-7.
41. Wielenga VJ, Smits R, Korinek V, et al. Expression of CD44 in Ape and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 1999;154:515-23.
42. Yan P, Muhlethaler A, Bourloud KB, Beck MN, Gross N. Hypermethylation- mediated regulation of CD44 gene expression in human neuroblastoma. Genes Chromosomes Cancer 2003;36:129-38.
43. Strobeck MW, DeCristofaro MF, Banine F, Weissman BE, Sherman LS, Knudsen ES. The BRG-1 subunit of the SWI/SNF complex regulates CD44 expression. J Biol Chem 2001;276:9273-8.
44. Hino S, Kishida S, Michiue T, et al. Inhibition of the Wnt signaling pathway by Idax, a novel Dvl-binding protein. Mol Cell Biol 2001;21:330-42.
45. London TB, Lee HJ, Shao Y, Zheng J. Interaction between the internal motif KTXXXI of Idax and mDvl PDZ domain. Biochem Biophys Res Commun 2004;322:326-32.
46. Schneider H, Bannister AJ, Myers FA, Thorne AW, Crane-Robinson C, Kouzarides T. Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat Cell Biol 2004;6:73-7.
47. Harikrishnan KN, Chow MZ, Baker EK, et al. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat Genet 2005;37:254-64.
48. Banine F, Bartlett C, Gunawardena R, et al. SWI/SNF chromatin-remodeling factors induce changes in DNA methylation to promote transcriptional activation. Cancer Res 2005;65:3542-7.
49. Gama-Sosa MA, Slagel VA, Trewyn RW, et al. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 1983;11:6883-94.
50. Rhee I, Bachman KE, Park BH, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002;416:552-6.
51. Biniszkiewicz D, Gribnau J, Ramsahoye B, et al. Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality. Mol Cell Biol 2002;22:2124-35.
52. Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 2000;405:486-9.
53. Hendricks KB, Shanahan F, Lees E. Role for BBG1 in cell cycle control and tumor suppression. Mol Cell Biol 2004;24:362-76.
54. Yamamichi N, Yamamichi-Nishina M, Mizutani T, et al. The Brm gene suppressed at the post-transcriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential. Oncogene 2005;24:5471-81.
55. Ito T, Ouchida M, Morimoto Y, et al. Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivo. Cancer Lett 2005;224:311-9.